Ellex Medical Lasers (ELXMF) 0.2900 $ELXMF Global

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ellex Medical Lasers (ELXMF) 0.2900 $ELXMF

Global Retinal Surgery Devices Market 2015-2019 with Alcon, Bausch & Lomb, Iridex & Synergetics USA Dominating
M2 - Sat Jan 31, 1:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/vfpj68/global_retinal) has announced the addition of the "Global Retinal Surgery Devices Market 2015-2019" report to their offering. The Global Retinal Surgery Devices market to grow at a CAGR of 7.32% over the period 2014-2019. The human eye is the most vital sensory organ. Ophthalmic diagnostic devices are used to identify and rectify ophthalmic disorders such as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, and dry eyes. Common eye problems can be caused by an infection or can be congenital. Continuous advances in the technology of ophthalmic devices ensure efficient diagnosis and treatment. Ophthalmic devices play a major role in treating loss of vision and improving quality of life of patients. Increased use of vitrectomy machines in the treatment of retinal detachment and vitreous hemorrhage is one key trend in this market. This is because of the availability of high-quality vitrectomy machines in the market with a cutting speed of approximately 2,500 cuts/min. According to the report, increase in aging population is one of the major drivers in the market. The growing incidence of retinal disorders, such as diabetic retinopathy, AMD, macular degeneration, retinal tear, and retinal detachments among the elderly results in increased demand for retinal surgeries to prevent loss of vision. Further, the report states that the presence of substitutes for retinal surgeries is one of the major challenges that the market faces. There are several drugs available in the market for the treatment of retinal disorders. The Global Retinal Surgery Devices market is divided into four segments: Vitrectomy Packs, Retinal Lasers, Vitrectomy Machines and Others (Retinal implants, scleral buckles, light sources, light pipes, cryosurgery devices, retinal laser probes, and surgical instruments). Key Vendors - Alcon - Bausch & Lomb - Iridex - Synergetics USA Other Prominent Vendors - ASICO - Beaver-Visitec International - Biotech Visioncare - Carl Zeiss Meditec - Ellex Medical Lasers - Erbe Elektromedizin - Escalon Medical - Geuder - Insight Instruments - Lumenis - Nano Retina - Oertli Instrumente - Peregrine Surgical - Quantel Medical - Retina Implant - Rhein Medical - Second Sight Medical Products Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product Type - Incidence and Prevalence of Retinal Disorders - Regulatory Environment - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/vf...al_retinal
EYES: 11.89 (-0.57), ESMC: 1.47 (-0.10)

Global Ophthalmic Lasers Market 2014-2018: Key Vendors are Alcon, Ellex Medical Lasers, Lumenis and Topcon
PR Newswire Europe - Wed Nov 26, 4:17PM CST
Research and Markets [http://www.researchandmarkets.com/research/5pf52d/global_ophthalmic] has announced the addition of the "Global Ophthalmic Lasers Market 2014-2018" [http://www.researchandmarkets.com/research/5pf52d/global_ophthalmic] report to their offering.

Global Ophthalmic Lasers Market 2014-2018: Photocoagulating, Photodisrupting & Selective Laser Trabeculoplasty Ophthalmic Lasers Analysis
M2 - Wed Oct 22, 3:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wgkn2l/global_ophthalmic) has announced the addition of the "Global Ophthalmic Lasers Market 2014-2018" report to their offering. The analysts forecast the Global Ophthalmic Lasers market to grow at a CAGR of 3.53% over the period 2013-2018 Ophthalmic lasers are diagnostic and therapeutic devices used in the field of ophthalmology. They are used to treat various eye diseases such as tumors, glaucoma, age-related macular degeneration, diabetic retinopathy, retinal disorders, and cataract and vision correction problems. These devices are highly accurate and affective as they allow patients to return home on the day of surgery, avoiding hospital stay or extended recovery time. One key trend emerging in the market is the increased popularity among surgeons for femtosecond lasers for cataract surgeries. These lasers help to reduce the complex steps in traditional cataract surgery. According to the report, an increase in the aging population worldwide is one of the major drivers of the market, which has led to an increase in age-related ophthalmic disorders such as AMD, cataracts, and diabetic retinopathy, which has raised the demand for ophthalmic lasers for treatment. Further, the report states that the presence of the potential risk of complications associated with LASIK procedures is proving to be a hindrance to the adoption of these devices. Complications include opaque bubble layer, transient light sensitivity syndrome, rainbow glare, and lamellar keratitis. The Global Ophthalmic Lasers market is divided into three segments: - Photocoagulating Ophthalmic Lasers - Photodisrupting Ophthalmic Lasers - Selective Laser Trabeculoplasty Ophthalmic Lasers Key Vendors - Alcon - Ellex Medical Lasers - Lumenis - Topcon Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Technology - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/wg...ophthalmic

Global Ophthalmic Instrumentation Strategic Business Report 2014-2020: Factors Underpinning Demand for Ophthalmic Instrumentation
M2 - Tue Jul 15, 8:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/k2qzpz/ophthalmic) has announced the addition of the "Ophthalmic Instrumentation - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Ophthalmic Instrumentation in Units and US$ Thousands by the following Product Segments: Diagnostic Devices (OCT Systems/Ophthalmoscopes, Optical Biometers, Slit Lamps, Tonometers, AutoRefractors & Keratometers, Perimeters, Fundus Cameras, Diagnostic Ultrasound Equipment, Others), and Surgical Products (Ophthalmic Lasers, & Ophthalmic Surgical Microscopes). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 113 companies including many key and niche players such as: - Abbott Medical Optics, Inc. - Alcon, Inc. - Bausch & Lomb, Inc. - Carl Zeiss Meditec AG - Ellex Medical Lasers Limited Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends & Issues 3. Competitive Scenario 4. Product Overview 5. Ophthalmic Surgery Market Overview 6. An Insight Into Eye & Eye Diseases 7. Product Introductions/Approvals 8. Recent Industry Activity 9. Focus On Select Global Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 113 (including Divisions/Subsidiaries 130) - The United States (56) - Canada (5) - Japan (11) - Europe (39) - France (6) - Germany (15) - The United Kingdom (6) - Italy (4) - Rest of Europe (8) - Asia-Pacific (Excluding Japan) (15) - Middle East (4) For more information visit http://www.researchandmarkets.com/research/k2qzpz/ophthalmic

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fault Codes vs. Diagnosis: What's the Real Fix?

Updated Category News Views 66

When a Blink Isn’t the Whole Story Ever sat in your car, watched that check engine light flicker on, and felt your heart drop? Yeah, we've all been there. But here’s the kicker: just ‘cause that little demon’s glowing doesn’t mean your mechanic’s got all the answers. That’s where this HelloNation article steps in, trying to shed some light on the difference...

Continue Reading
National CORE Retains A+ Rating as Housing Demand Soars

Updated Category News Views 55

A Rating That Speaks Volumes in Affordable Housing Fresh out of Rancho Cucamonga, National CORE's announcement of its A+ credit rating reaffirmation is no small potatoes. For the fourth consecutive year, Standard & Poor's Global Ratings has found that this nonprofit affordable housing developer checks all the right boxes for financial strength and strategic prowess. It's...

Continue Reading
HOST's $50M Boost Fuels Avondale's Expansion

Updated Category News Views 54

Big Bucks for Avondale's Next Leap HOST isn't playing around with pocket change here. The company's coughing up a neat $50 million to propel Avondale Global Gateway into its next chapter. This investment means serious business—it’s cranking up capacity like a power plant on overdrive, laying down more rail, warehouse spaces, and dock improvements. A new...

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 138

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
Lear Capital Hits $5 Billion Milestone: Trust or Hype?

Updated Category News Views 114

A Golden Milestone or Just Glitter? Lear Capital's announcement of surpassing $5 billion in precious metals transactions feels like one of those moments where you tilt your head and ask, "Is it really what it seems?" With nearly 150,000 customers and almost three decades of hustling in the glittering world of gold and silver, they've certainly carved out a name in the...

Continue Reading
Caesarstone Loses $67.7M Case Over Artificial Stone Risks

Updated Category News Views 0

A Demand for Accountability in the Courts A Los Angeles jury recently handed down a whopping $67.7 million verdict against Caesarstone Ltd. and its U.S. operations, marking a win for Dennys Rene Rivas Williams and his family. No sugarcoating here—this is a landmark case for artificial stone fabricators suffering from silicosis. The jury found Caesarstone entities a...

Continue Reading
North Fork Mono Casino Opens: A $750 Million Bet

Updated Category News Views 62

A New Spin in Madera Cue the fanfare, folks! The North Fork Mono Casino just threw open its doors earlier than expected today, marking a hefty $750 million wager right in the heart of California's Central Valley. It's a big deal managed by Station Casinos, part of Red Rock Resorts, Inc. (NASDAQ: RRR)—teaming up with the North Fork Rancheria of Mono Indians for a...

Continue Reading
Scania's Q3 Results: A Resilient Yet Uneven Ride

Updated Category News Views 71

Scania Steadies the Ship in Q3 with Robust Growth Sailing through a patchy global market, Swedish powerhouse Scania's latest quarterly figures reflect a mixed bag of results. Their performance in this third quarter of 2026 stood strong, despite some wobbles. The company showed resilience in sales and profitability, with numbers telling a tale that's a bit like a truck...

Continue Reading
FirstEnergy Funds Boost Housing Stability Across States

Updated Category News Views 146

FirstEnergy's Commitment to Shelter and Safety You know what gives a warm feeling even in the cold, hard world of finance? Watching a company like FirstEnergy put their money where their mouth is with real action in the community. They're dishing out $125,000 in grants across West Virginia and Maryland, targeting groups that help folks dodging homelessness and domestic...

Continue Reading
DexCom Faces Scrutiny: Fiduciary Breach Questioned

Updated Category News Views 280

Is DexCom’s Leadership Under The Gun? Here's the scoop, folks—DexCom, Inc. (NASDAQ:DXCM) has been hit with some serious questions recently. Nothing like a potential fiduciary breach to shake things up. October 27, 2026, is when the news broke, with Halper Sadeh LLC taking the reins on this investigation. They’re poking around to see if DexCom’s top dogs stumbled...

Continue Reading

Top 5 Most Recently Viewed Articles

Howard Marks Analyzes AI Hype and Dot-Com Echoes in Market Trends

Updated Category News Views 192

Howard Marks Insights on Current AI Market Dynamics Respected investor Howard Marks draws significant comparisons between today’s enthusiasm for artificial intelligence (AI) and the infamous dot-com bubble of the late 1990s. He notes that identifying the long-term winners among the current wave of AI innovations is uncertain at best. Market Sentiment Transitioning from...

Continue Reading
Agnico Eagle Expands Portfolio with O3 Mining Acquisition

Updated Category News Views 161

Agnico Eagle Completes Full Acquisition of O3 Mining Agnico Eagle Mines Limited (NYSE: AEM) has successfully completed the acquisition of 100% of the outstanding common shares of O3 Mining Inc. This strategic move solidifies Agnico Eagle's position in the market and expands its asset base significantly. The acquisition was finalized through an amalgamation, integrating O3...

Continue Reading
Breakthrough Study Validates Relexxii's Comparability to Concerta

Updated Category News Views 276

New Insights on Relexxii's Efficacy Alora Pharmaceuticals, a notable player in the pharmaceutical industry, has recently announced groundbreaking findings regarding its extended-release formulation of Relexxii. This new research indicates that Relexxii is bioequivalent to the well-known reference product, Concerta, which has been a common treatment option for...

Continue Reading
Exploring the Explosive Growth of the Sports Apparel Industry

Updated Category News Views 194

The Growth of the Sports Apparel Market The global demand for sports apparel is on the rise, leading to significant growth in the industry. With cutting-edge designs and advanced technologies driving this trend, the market is projected to grow from USD 209.56 billion in 2023 to a remarkable USD 347.91 billion by 2033. This expansion is largely attributed to a growing...

Continue Reading
Peloton's Upcoming Conference Appearance: What to Know

Updated Category News Views 231

Peloton Interactive's Conference Participation Details Peloton Interactive, Inc. has officially announced an exciting opportunity for discussion and insights into their fitness solutions. Chief Financial Officer Liz Coddington will take part in a fireside chat at a prominent technology and media conference. This event is designed to engage with investors and provide...

Continue Reading